Prevalence of epidermal growth factor receptor (EGFR) mutations and correlation with histological patterns in lung adenocarcinoma in patients from Bosnia and Herzegovina

Author:

Udovičić-Gagula Dalma1ORCID,Džananović Nejra2,Dorić Mirsad3

Affiliation:

1. Clinical Centre University in Sarajevo

2. Clinical Centre University of Sarajevo

3. University of Sarajevo

Abstract

<p><strong>Aim</strong> <br />Lung adenocarcinoma (ADC) is a leading subtype of lung cancer, histologically defined with five different architectural<br />growth patterns: lepidic, acinar, papillary, solid and micropapillary. The aim of this study was to explore the prevalence of epidermal growth factor receptor (EGFR) mutation and a relationship between the specific histological patterns of lung ADC in the population of Bosnia and Herzegovina.<br /><strong>Methods <br /></strong>The study included tumour tissue from 102 patients with completely resected lung ADC from 2015 to 2020. Molecular testing for the presence of EGFR mutations was performed by real-time PCR method. The relationship between EGFR mutation status and clinicopathological parameters was analysed.<br /><strong>Results</strong> <br />The EGFR mutation was detected in 12 (11.8%) cases of ADC, more often in non-smokers (p=0.007). A higher percentage<br />of solid growth pattern presented in ADC may be an indicator of EGFR negativity (p=0.039), while a higher percentage of micropapillary growth pattern more common in the presence of EGFR mutation (p=0.047).<br /><strong>Conclusion</strong> <br />The prevalence of EGFR mutation is in accordance with the expected prevalence considering our studied population,<br />Caucasians from South Europe. Better understanding of the relationship between histological patterns and molecular characteristics of lung ADC will enable earlier diagnosis and optimal treatment for patients.</p>

Publisher

Medical Association of Zenica-Doboj

Reference44 articles.

1. Global Cancer Observatory: Cancer Today;J.Ferlay,2020

2. World Cancer Research Fund International. Lung cancer statistics,2023-02-16

3. WHO Classification of Tumours of the Lung, Pleura, Thymus and Heart;W.D.Travis,2015

4. Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology;N.I.Lindeman;J Thorac Oncol,2013

5. Oncogenic driver mutations in non-small cell lung cancer: past, present and future;M.Chevallier;World J Clin Oncol,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3